Loading...
Tenet Healthcare Corporation
THC•NYSE
HealthcareMedical - Care Facilities
$171.38
$-0.46(-0.27%)
Tenet Healthcare Corporation (THC) Financial Performance & Statements
Review Tenet Healthcare Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.57%
↑ 0.57%
Operating Income Growth
137.29%
↑ 137.29%
Net Income Growth
423.73%
↑ 423.73%
Operating Cash Flow Growth
-13.77%
↓ 13.77%
Operating Margin
17.17%
↑ 17.17%
Gross Margin
47.32%
↑ 47.32%
Net Profit Margin
7.09%
↑ 7.09%
ROE
37.16%
↑ 37.16%
ROIC
14.22%
↑ 14.22%
Tenet Healthcare Corporation (THC) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Tenet Healthcare Corporation stock.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $5.07B | $5.12B | $5.10B | $5.37B |
Cost of Revenue | $930.00M | $3.33B | $4.43B | $4.61B |
Gross Profit | $4.14B | $1.79B | $671.00M | $757.00M |
Gross Profit Ratio | $0.82 | $0.35 | $0.13 | $0.14 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $2.09B | $2.22B | $2.17B | $2.32B |
Operating Expenses | $3.32B | $704.00M | $3.52B | $3.68B |
Total Costs & Expenses | $4.25B | $4.03B | $4.43B | $4.61B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $203.00M | $202.00M | $203.00M | $218.00M |
Depreciation & Amortization | $193.00M | $209.00M | $208.00M | $208.00M |
EBITDA | $1.05B | $1.33B | $882.00M | $1.03B |
EBITDA Ratio | $0.21 | $0.26 | $0.17 | $0.19 |
Operating Income | $821.00M | $1.09B | $671.00M | $757.00M |
Operating Income Ratio | $0.16 | $0.21 | $0.13 | $0.14 |
Other Income/Expenses (Net) | -$166.00M | -$167.00M | -$174.00M | -$201.00M |
Income Before Tax | $655.00M | $922.00M | $587.00M | $3.08B |
Income Before Tax Ratio | $0.13 | $0.18 | $0.12 | $0.57 |
Income Tax Expense | $83.00M | $241.00M | $110.00M | $750.00M |
Net Income | $318.00M | $472.00M | $259.00M | $2.15B |
Net Income Ratio | $0.06 | $0.09 | $0.05 | $0.40 |
EPS | $3.29 | $4.94 | $2.66 | $21.60 |
Diluted EPS | $3.26 | $4.89 | $2.64 | $21.38 |
Weighted Avg Shares Outstanding | $96.28M | $95.67M | $97.27M | $99.58M |
Weighted Avg Shares Outstanding (Diluted) | $97.27M | $96.65M | $98.44M | $100.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan